Skip Navigation



Annals of Oncology Advance Access published online on January 17, 2007
Annals of Oncology, doi:10.1093/annonc/mdl466
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
18/4/652    most recent
mdl466v1
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Rodríguez, J
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Rodríguez, J
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© 2007 European Society for Medical Oncology

The results of consolidation with autologous stem-cell transplantation in patients with peripheral T-cell lymphoma (PTCL) in first complete remission: the Spanish Lymphoma and Autologous Transplantation Group experience

J Rodríguez1,*, E Conde2, A Gutiérrez3, R Arranz4, Á León5, J Marín6, M Bendandi7, C Albo8, MD Caballero9 On behalf of the Grupo Español de Linfomas/Trasplante Autólogo de Médula Ósea

1 Hospital Universitario Son Dureta (Service of Oncology), Palma
2 Hospital de Valdecilla, Santander
3 Hospital Universitario Son Dureta (Service of Hematology), Palma
4 Hospital La Princesa, Madrid
5 Hospital de Jerez de la Frontera, Cádiz
6 Hospital Nuestra Señora de Aránzazu, San Sebastián
7 Clínica de Navarra, Pamplona
8 Hospital Xeral-Cies, Pontevedra
9 Hospital Clínico de Salamanca, Spain

* Correspondence to: Dr J. Rodríguez, Service of Oncology, University Hospital Son Dureta, Av/Andrea Doria 55, Palma de Mallorca 07014, Spain. Tel: +34-971-175000; Fax: +34-971-175500; E-mail: jrodriguez{at}hsd.es

Background: Peripheral T-cell lymphoma (PTCL) is a heterogeneous group of aggressive lymphomas associated with poor prognosis with standard chemotherapy. Consolidation with autologous stem-cell transplantation (ASCT) may improve survival. We present 74 patients transplanted in first complete response (CR) from the Spanish Lymphoma and Autologous Transplantation Group cooperative group.

Patients and methods: Median age was 46 years. Eighty-eight percent presented advanced (III–IV) Ann Arbor stage; 53% had B symptoms; 52% had high lactate dehydrogenase; 65% had two or three risk factors of the adjusted-International Prognostic Index; 58% presented a high Tumor score and in 14% more than two adverse factors of the Prognostic Index for peripheral T-cell lymphoma (PIT) were observed.

Results: With a median follow-up of 67 months from diagnosis, the 5-year overall survival (OS) was 68% and progression-free survival (PFS) reached 63%. The multivariate analysis showed that the only factor associated with a shorter OS and PFS was the presence of more than two risk factors from the PIT risk system.

Conclusions: In a retrospective study with a prolonged follow-up, consolidation with ASCT in CR patients who had presented unfavorable prognostic factors at diagnosis substantially increased the OS and PFS when compared with conventional chemotherapy. The PIT risk system identified 14% of patients without benefit from ASCT consolidation. Thus, other innovative therapies are still necessary in certain cases.

autologous stem-cell transplantation, complete response, consolidation, front-line, peripheral T-cell lymphoma


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 JCOHome page
P. Reimer, T. Rudiger, E. Geissinger, F. Weissinger, C. Nerl, N. Schmitz, A. Engert, H. Einsele, H. K. Muller-Hermelink, and M. Wilhelm
Autologous Stem-Cell Transplantation As First-Line Therapy in Peripheral T-Cell Lymphomas: Results of a Prospective Multicenter Study
J. Clin. Oncol., January 1, 2009; 27(1): 106 - 113.
[Abstract] [Full Text] [PDF]

Home page
 JCOHome page
International T-Cell Lymphoma Project
International Peripheral T-Cell and Natural Killer/T-Cell Lymphoma Study: Pathology Findings and Clinical Outcomes
J. Clin. Oncol., September 1, 2008; 26(25): 4124 - 4130.
[Abstract] [Full Text] [PDF]

Home page
 J. Thorac. Cardiovasc. Surg.Home page
P. L. Wagner, W. Tam, P. Y. Lau, J. L. Port, S. Paul, N. K. Altorki, and P. C. Lee
Primary esophageal large T-cell lymphoma mimicking esophageal carcinoma: A case report and literature review.
J. Thorac. Cardiovasc. Surg., April 1, 2008; 135(4): 957 - 958.e1.
[Full Text] [PDF]

Home page
 ASH Education BookHome page
A. R. Shustov and K. J. Savage
Does High-Dose Therapy and Autologous Hematopoietic Stem Cell Transplantation Have a Role in the Primary Treatment of Peripheral T-Cell Lymphomas?
Hematology, January 1, 2008; 2008(1): 39 - 41.
[Abstract] [Full Text] [PDF]

Home page
 ASH Education BookHome page
S. M. Horwitz
Novel Therapies and Role of Transplant in the Treatment of Peripheral T-Cell Lymphomas
Hematology, January 1, 2008; 2008(1): 289 - 296.
[Abstract] [Full Text] [PDF]


Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.